Ciprofloxacin tablets belong to fluoroquinolone class of antibacterial drugs, the main effective ingredient is ciprofloxacin, through acting on the helicase of pathogen DNA, so as to inhibit the synthesis of pathogen DNA, play an antibacterial role.Ciprofloxacin is a broad-spectrum antibacterial drug, which has a good antibacterial effect on a variety of pathogenic bacteria, such as Gram-positive bacteria, gram-negative bacteria and some atypical pathogens, especially gram-negative bacteria.Meanwhile, ciprofloxacin has obvious antibacterial effect on Escherichia coli, Klebsiella pneumoniae, Salmonella, Shigella and Pseudomonas aeruginosa.
Reyoung Pharmaceutical Co., Ltd., established in 1966, is one of the leading manufacturer and distributor of pharmaceutical products in China. Reyoung Pharma is certificated by GMP, ISO9001, ISO14001, OHS18001. The trademark "REYOUNG" is famous trademark of China.
Reyoung Pharma has three main factories which covers an area of 1,000,000 square meters and owns total asset of more than 1.5 billion USD dollar. Reyoung Pharma has 30 workshops that can produce ten categories and more than 400 specifications of pharmaceutical products including tablets, capsules, granules, sterile active ingredients, small volume injection, powder for injection, lyophilized powder for injection, suppository, traditional Chinese medicine and aerosol. The annual production capacity can reach 2.5 billion vials of powder for injection, 300 million ampoules of liquid injection, 4 billion tablets, 6 billion capsules and 200 million bags granule of solid formulation, and 2000 tons API respectively.
As a professional pharmaceutical manufacturer, Reyoung Pharma is the first enterprise to manufacture powder for injection in Shandong province. The sales and marketing network for its products covers more than 70 countries all over the world.
Reyoung Pharma commenced international business and exported products in 1997. Reyoung Pharma, with an excellent sales & documentation team, owned over 20 years experience in the international transaction and registered products in different countries. Reyoung Pharma has passed the GMP inspection of Colombia, Peru, Congo, Ethiopia, Uganda, Nigeria, Ghana, Tanzania, Kenya, Cote d′Ivoire, Pakistan, Ukraine, Philippines, Cambodia, etc. Products have been exported to Asia, South America, Africa, CIS Countries, Middle East and Europe including Thailand, Philippines, Cambodia, Hong Kong, Vietnam, India, Pakistan, Colombia, Peru, Chile, Costa Rica, Venezuela, Congo, Ethiopia, Uganda, Nigeria, Tanzania, Kenya, Cameroon, Russia, Kazakhstan, Ukraine, Uzbekistan, Georgia, Yemen, Iraq, Germany, Denmark, and so on.
Look into the future, as entering into the market successively of the new products, the product structure of Reyoung Pharma will be upgraded, the producing levels and the market-controlling power will be enhanced further, and Reyoung Pharma will provide a wider platform for our old and new friends to go hand in hand and seek common development.
Complaint
